CASI - CASI Pharmaceuticals, Inc (DE)
1.8854
-0.052 -2.763%
Share volume: 3,314
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.94
-0.05
-0.03%
Summary score
11%
Profitability
8%
Dept financing
5%
Liquidity
75%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.67%
Return on assets
-8.69%
Return on sales
0%
Return on invested capital
52.87%
Total debt ratio
24.38%
Debt ratio change over timeo
0%
Current Ratio
14.48%
Quick Ratio
22.19%
Cash Position Ratio
13.93%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.76%
Return on assets
-7.02%
Return on sales
0%
Return on invested capital
-51.79%
Total debt ratio
8.64%
Debt ratio change over timeo
0%
Current Ratio
21.51%
Quick Ratio
21.42%
Cash Position Ratio
20.27%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-7.84%
Return on assets
-6.31%
Return on sales
0%
Return on invested capital
-44.49%
Total debt ratio
20.5%
Debt ratio change over time
0%
Current Ratio
21.52%
Quick Ratio
21.46%
Cash Position Ratio
19.93%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CASI | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -13.67% | 8.13% | 9.3% | 0% |
| Return on assets | -8.69% | 3.4% | 5.35% | 0% |
| Return on sales | 0% | 43.52% | 48.98% | 0% |
| Return on invested capital | 52.87% | 7.97% | 8.31% | 0% |
| Profitability | 25% | 64% | 79% | 0% |
| Total debt ratio | 24.38% | 68.62% | 66.39% | 0% |
| Debt ratio change over time | 0% | 0% | 750.51% | 0% |
| Dept financing | 9% | 25% | 49% | 0% |
| Current Ratio | 21.51% | 3.01% | 3.36% | 0% |
| Quick Ratio | 21.42% | 2.76% | 3.28% | 0% |
| Cash Position Ratio | 20.27% | 0.74% | 2.77% | 0% |
| Liquididy | 75% | 13% | 11% | 0% |
| Short-term ratios | CASI | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -7.76% | 15.54% | 6.64% | 0% |
| Return on assets | -7.02% | 3.77% | 3.23% | 0% |
| Return on sales | 0% | 42.29% | 37.34% | 0% |
| Return on invested capital | -51.79% | 12.14% | 7.36% | 0% |
| Profitability | 0% | 100% | 69% | 0% |
| Total debt ratio | 8.64% | 80.23% | 65.69% | 0% |
| Debt ratio change over time | 0% | 0% | 939.58% | 0% |
| Dept financing | 3% | 25% | 45% | 0% |
| Current Ratio | 21.51% | 3.01% | 3.36% | 0% |
| Quick Ratio | 21.42% | 2.76% | 3.28% | 0% |
| Cash Position Ratio | 20.27% | 0.74% | 2.77% | 0% |
| Liquididy | 75% | 8% | 11% | 0% |
